Illinois Tool Works Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $75.1 Billion | 3/12 | ETN $125.3B |
PH $78.3B |
ITW $75.1B |
EMR $59.4B |
CMI $41.2B |
IR $37.8B |
XYL $32.3B |
ROK $29.8B |
DOV $25.6B |
PNR $15.5B |
AOS $12.1B |
FELE $4.6B |
Gross Margin | 43% | 2/12 | EMR 47% |
ITW 43% |
PNR 40% |
IR 39% |
AOS 39% |
ROK 39% |
DOV 38% |
ETN 38% |
XYL 38% |
FELE 37% |
PH 36% |
CMI 25% |
Profit Margin | 19% | 1/12 | ITW 19% |
PNR 17% |
ETN 16% |
PH 15% |
AOS 15% |
DOV 13% |
ROK 11% |
FELE 11% |
IR 10% |
XYL 9% |
EMR 8% |
CMI 8% |
EBITDA margin | 29% | 1/12 | ITW 29% |
EMR 28% |
PNR 27% |
IR 26% |
PH 25% |
ETN 23% |
AOS 22% |
DOV 21% |
XYL 19% |
ROK 18% |
FELE 17% |
CMI 14% |
Quarterly Revenue | $4.0 Billion | 5/12 | CMI $8.8B |
ETN $6.4B |
PH $5.2B |
EMR $4.4B |
ITW $4.0B |
DOV $2.2B |
XYL $2.2B |
ROK $2.1B |
IR $1.8B |
PNR $1.1B |
AOS $1.0B |
FELE $543.3M |
Quarterly Earnings | $759.0 Million | 3/12 | ETN $993.0M |
PH $785.0M |
ITW $759.0M |
CMI $726.0M |
EMR $329.0M |
DOV $281.8M |
ROK $230.9M |
XYL $194.0M |
PNR $186.1M |
IR $185.0M |
AOS $156.2M |
FELE $59.1M |
Quarterly Free Cash Flow | $571.0 Million | 4/12 | PH $1.1B |
EMR $998.0M |
ETN $759.0M |
ITW $571.0M |
PNR $522.2M |
IR $283.1M |
ROK $238.4M |
XYL $215.0M |
DOV $162.8M |
AOS $34.5M |
FELE $26.1M |
CMI -$1.1B |
Trailing 4 Quarters Revenue | $16.0 Billion | 5/12 | CMI $34.2B |
ETN $24.1B |
PH $19.9B |
EMR $17.0B |
ITW $16.0B |
DOV $8.5B |
IR $7.0B |
XYL $6.4B |
ROK $6.2B |
PNR $4.1B |
AOS $3.9B |
FELE $2.0B |
Trailing 4 Quarters Earnings | $3.1 Billion | 2/12 | CMI $8.8B |
ETN $6.4B |
PH $5.2B |
EMR $4.4B |
ITW $4.0B |
DOV $2.2B |
XYL $2.2B |
ROK $2.1B |
IR $1.8B |
PNR $1.1B |
AOS $1.0B |
FELE $543.3M |
Quarterly Earnings Growth | 1% | 7/12 | XYL 111% |
ETN 33% |
PNR 22% |
DOV 16% |
PH 11% |
IR 3% |
ITW 1% |
CMI 1% |
AOS -1% |
FELE -2% |
ROK -42% |
EMR -96% |
Annual Earnings Growth | 6% | 9/12 | XYL 97% |
DOV 62% |
ETN 37% |
IR 25% |
PNR 22% |
PH 15% |
FELE 9% |
AOS 7% |
ITW 6% |
ROK -21% |
CMI -37% |
EMR -84% |
Quarterly Revenue Growth | -1% | 11/12 | ROK 124% |
XYL 26% |
EMR 11% |
ETN 8% |
IR 7% |
AOS 7% |
DOV 4% |
CMI 2% |
PNR 2% |
PH 2% |
ITW -1% |
FELE -5% |
Annual Revenue Growth | -1% | 9/12 | EMR 11% |
ETN 8% |
IR 7% |
XYL 5% |
DOV 2% |
AOS 2% |
CMI 1% |
FELE 0% |
ITW -1% |
PNR -1% |
PH -2% |
ROK -19% |
Cash On Hand | $862.0 Million | 4/12 | EMR $2.3B |
CMI $1.6B |
IR $1.1B |
ITW $862.0M |
XYL $815.0M |
ETN $540.0M |
PH $422.0M |
ROK $406.7M |
DOV $328.8M |
AOS $216.1M |
PNR $214.3M |
FELE $58.1M |
Short Term Debt | $2.0 Billion | 4/12 | PH $3.4B |
EMR $3.1B |
CMI $2.2B |
ITW $2.0B |
ETN $1.3B |
ROK $1.2B |
DOV $210.5M |
XYL $123.0M |
FELE $60.6M |
IR $51.6M |
PNR $28.8M |
AOS $10.0M |
Long Term Debt | $6.4 Billion | 4/12 | ETN $8.6B |
PH $7.2B |
EMR $7.1B |
ITW $6.4B |
CMI $5.3B |
IR $4.8B |
DOV $3.0B |
ROK $2.6B |
XYL $2.0B |
PNR $1.8B |
AOS $130.4M |
FELE $87.2M |
PE | 24.49 | 8/12 | IR 45.83 |
XYL 42.18 |
EMR 34.81 |
ETN 34.31 |
ROK 29.37 |
PH 27.54 |
FELE 24.58 |
ITW 24.49 |
PNR 23.45 |
CMI 21.20 |
AOS 20.97 |
DOV 17.04 |
PS | 4.69 | 5/12 | IR 5.38 |
ETN 5.19 |
XYL 5.07 |
ROK 4.78 |
ITW 4.69 |
PH 3.93 |
PNR 3.76 |
EMR 3.50 |
AOS 3.08 |
DOV 3.00 |
FELE 2.30 |
CMI 1.21 |
PB | 25.36 | 1/12 | ITW 25.36 |
ROK 8.51 |
ETN 6.51 |
PH 6.48 |
AOS 6.32 |
DOV 4.76 |
PNR 4.51 |
CMI 3.90 |
FELE 3.78 |
IR 3.77 |
XYL 3.12 |
EMR 2.22 |
PC | 87.13 | 3/12 | ETN 231.97 |
PH 185.58 |
ITW 87.13 |
FELE 79.70 |
DOV 77.74 |
ROK 73.30 |
PNR 72.19 |
AOS 55.94 |
XYL 39.60 |
IR 35.60 |
CMI 25.91 |
EMR 25.84 |
Liabilities to Equity | 4.26 | 1/12 | ITW 4.26 |
ROK 2.31 |
CMI 2.17 |
PH 1.43 |
DOV 1.11 |
ETN 1.05 |
EMR 0.91 |
PNR 0.91 |
IR 0.78 |
AOS 0.67 |
XYL 0.52 |
FELE 0.46 |
ROA | 0.20 | 1/12 | ITW 20% | AOS 18% | DOV 13% | FELE 11% | PNR 10% | PH 10% | ETN 9% | ROK 9% | CMI 6% | IR 5% | XYL 5% | EMR 4% |
ROE | 1.04 | 1/12 | ITW 104% |
ROK 31% |
AOS 30% |
DOV 28% |
PH 24% |
CMI 20% |
ETN 19% |
PNR 19% |
FELE 15% |
EMR 8% |
IR 8% |
XYL 7% |
Current Ratio | 1.23 | 12/12 | FELE 3.20 |
XYL 2.91 |
AOS 2.49 |
EMR 2.41 |
IR 2.28 |
PNR 2.10 |
ETN 1.96 |
DOV 1.90 |
PH 1.70 |
CMI 1.51 |
ROK 1.46 |
ITW 1.23 |
Quick Ratio | 0.07 | 8/12 | IR 45.83 |
XYL 42.18 |
EMR 34.81 |
ETN 34.31 |
ROK 29.37 |
PH 27.54 |
FELE 24.58 |
ITW 24.49 |
PNR 23.45 |
CMI 21.20 |
AOS 20.97 |
DOV 17.04 |
Long Term Debt to Equity | 2.17 | 1/12 | ITW} 2.17 |
ROK} 0.77 |
PH} 0.59 |
CMI} 0.56 |
DOV} 0.55 |
PNR} 0.51 |
IR} 0.48 |
ETN} 0.45 |
EMR} 0.34 |
XYL} 0.19 |
AOS} 0.07 |
FELE} 0.07 |
Debt to Equity | 2.86 | 1/12 | ITW 2.86 |
ROK 1.23 |
PH 0.87 |
CMI 0.83 |
DOV 0.59 |
ETN 0.55 |
PNR 0.55 |
EMR 0.52 |
IR 0.48 |
XYL 0.20 |
FELE 0.16 |
AOS 0.09 |
Burn Rate | 94.10 | 1/12 | ITW 94.10 |
IR 59.24 |
CMI 41.71 |
EMR 3.10 |
ROK 2.32 |
PH 1.20 |
FELE -1.44 |
AOS -1.46 |
ETN -1.63 |
PNR -1.97 |
DOV -2.97 |
XYL -9.70 |
Cash to Cap | 0.01 | 6/12 | EMR 0.04 |
CMI 0.04 |
IR 0.03 |
XYL 0.03 |
AOS 0.02 |
ITW 0.01 |
DOV 0.01 |
PNR 0.01 |
PH 0.01 |
ROK 0.01 |
FELE 0.01 |
ETN 0.00 |
CCR | 0.75 | 8/12 | EMR 3.03 |
PNR 2.81 |
IR 1.53 |
PH 1.43 |
XYL 1.11 |
ROK 1.03 |
ETN 0.76 |
ITW 0.75 |
DOV 0.58 |
FELE 0.44 |
AOS 0.22 |
CMI -1.50 |
EV to EBITDA | 71.74 | 5/12 | ETN} 93.64 |
ROK} 91.22 |
IR} 87.08 |
XYL} 79.90 |
ITW} 71.74 |
PH} 69.31 |
DOV} 61.18 |
PNR} 58.31 |
EMR} 56.07 |
AOS} 53.20 |
FELE} 51.21 |
CMI} 39.10 |
EV to Revenue | 5.17 | 5/12 | IR 5.91 |
ETN 5.60 |
ROK 5.37 |
XYL 5.27 |
ITW 5.17 |
PH 4.44 |
PNR 4.17 |
EMR 4.00 |
DOV 3.33 |
AOS 3.06 |
FELE 2.36 |
CMI 1.39 |